Galapagos Cystic Fibrosis Drug Enters Phase I, Triggering €8.5M Payout
Galapagos will receive a $10M (€8.5M) milestone payment from its collaborator, AbbVie, after their cystic fibrosis candidate started a...


Advances in the Prevention and Treatment of MRSA in Patients with Cystic Fibrosis
Active research and special expertise at Cleveland Clinic’s Adult CF Center Methicillin-resistant Staphylococcus aureus (MRSA) increases...


Spyryx Presents Data Ably Supporting SPX-101 as Potential Treatment for All CF Patients
Spyryx Biosciences recently presented preclinical data supporting the clinical benefits of its cystic fibrosis (CF) treatment candidate...


Sclerosis medicine can fight multi-resistant bacteria
A surprising discovery shows that a widely used and 20-year-old medicine used to treat multiple sclerosis can also beat a type of...
Commission approves medical marijuana facilities
Stratford could eventually have two medical marijuana dispensaries in town, based on a Zoning Commission vote at the Nov. 14 meeting...


Case Report Provides New Insights on Dosing of Novel Drug for Patients with Cystic Fibrosis
Ceftolozane/tazobactam is safe, effective, and well-tolerated in the treatment of multidrug-resistant Pseudomonas aeruginosa infection...

